乌比斯类药物通过结合乌比奎链来抑制蛋白酶体依赖性降解
Rati Verma1, Noel R Peters, Mariapina D'Onofrio
1Department of Biology, Howard Hughes Medical Institute (HHMI), California Institute of Technology, Pasadena, CA 91125, USA.
概括
研究人员发现了ubistatins,这些新型小分子通过阻断关键蛋白质的蛋白酶体降解来阻止细胞循环的进展. 这些乌比斯类药物准了乌比奎链相互作用,破坏了乌比奎-蛋白酶体系统. 关键词:乌比斯塔丁,细胞循环,蛋白酶体,乌比奎-蛋白酶体系统.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 细胞循环是一个严格规范的过程,对细胞分裂至关重要.
- 在蛋白质降解和细胞周期控制中,无素-蛋白酶体系统 (UPS) 起着至关重要的作用.
- 抑制UPS的药物可以破坏细胞循环的进展.
研究的目的:
- 为了识别抑制细胞循环机制的新型小分子.
- 描述新发现的抑制剂的作用机制.
主要方法:
- 在Xenopus提取物中的化学遗传选.
- 在体外测试中使用纯化的蛋白质酶.
- 蛋白质降解和无处不在的分析.
主要成果:
- 确定了一种新的抑制剂类别,称为ubistatins.
- 乌比斯塔丁通过阻断环林B蛋白质分解来抑制细胞循环的进展.
- 乌比斯塔丁可以阻止蛋白质酶体对无处可见的Sic1的降解.
- 乌比斯类药物向Lys(48) 连接链的乌比奎-乌比奎接口,阻止基质与蛋白酶体结合.
结论:
- 乌比斯塔丁通过干扰关键的蛋白质-蛋白质相互作用来破坏乌比奎丁-蛋白质酶系统.
- 这些发现为研究UPS和细胞周期调节提供了新的工具.
- 乌比斯塔丁代表了涉及细胞循环失调的疾病的潜在治疗策略.
相关概念视频
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome Structure
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...


